Home/Filings/4/0001415889-24-010324
4//SEC Filing

Miller Aine 4

Accession 0001415889-24-010324

CIK 0001583107other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 6:13 PM ET

Size

4.6 KB

Accession

0001415889-24-010324

Insider Transaction Report

Form 4
Period: 2024-04-02
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
Transactions
  • Award

    Ordinary Shares

    2024-04-02+37,500171,034 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0002012524

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:13 PM ET
Size
4.6 KB